2743 studies found for:    received in the last 60 days
Show Display Options
Rank Status Study
1 Recruiting Down Syndrome Metabolic Health Study
Conditions: Down Syndrome;   Trisomy 21
Intervention:
2 Not yet recruiting New Media Obesity Treatment in Community Health Centers
Condition: Obesity
Intervention: Behavioral: eHealth weight loss intervention
3 Recruiting NIRS and Doppler to Predict NEC in Risk Neonates
Condition: Necrotizing Enterolitis
Intervention: Device: Cerebral and splanchnic ear infrared spectroscopy (NIRS) and mesenteric Doppler
4 Recruiting A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404)
Condition: Partial Onset Seizures
Intervention: Drug: Eslicarbazepine Acetate tablets
5 Completed Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
Condition: Fasting
Interventions: Drug: Lisinopril and Hydrochlorothiazide Tablets (20+25) mg;   Drug: Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets
6 Active, not recruiting The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Behavioral: Unsupervised exercise training;   Behavioral: Supervised exercise training
7 Recruiting Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy
Condition: Acute Upper Gastrointestinal Hemorrhage
Intervention: Device: Endoscopic hemostasis
8 Not yet recruiting Suspension of Mechanical Ventilation in Ureteroscopic Lithotripsy Under General Anesthesia
Conditions: Hypercapnia;   Hypoxia
Intervention: Other: PEEP
9 Completed Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
Conditions: Depressive Disorder;   Anxiety Disorders
Intervention: Behavioral: Group Behavioral Activation Therapy (GBAT)
10 Recruiting EVIDENCE: A Non-Interventional Study of Treatment and Clinical Outcomes in Chinese Patients With Gastric Cancer
Condition: Gastric Cancer
Intervention:
11 Recruiting A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumbab Therapy in Patients With Advanced Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: Bacillus Calmette-Guérin (BCG) vaccine;   Drug: Ipilimumab
12 Completed To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
Conditions: Induced Abortion;   Postaboral Pelvic Inflammatory Disease;   Sexually Transmitted Infections
Interventions: Drug: Universal antibiotic prophylaxis;   Other: Screen-and-treat
13 Not yet recruiting Regorafenib Post-marketing Surveillance
Condition: Colorectal Neoplasms
Intervention: Drug: BAY73-4506_Regorafenib
14 Not yet recruiting cSBI-M for Young Military Personnel
Conditions: Alcohol Abuse;   Tobacco Dependence;   Substance Abuse
Intervention: Behavioral: cSBI-M
15 Recruiting Low-level Laser Therapy on Temporomandibular Disorder
Condition: Temporomandibular Disorder
Intervention: Procedure: low-level laser treatment
16 Recruiting Preconception Reproductive Knowledge Promotion (PREKNOP)
Condition: Pregnancy
Interventions: Other: Knowing your body;   Behavioral: Healthy Lifestyle
17 Not yet recruiting Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors
Condition: Germ Cell Cancer
Intervention: Drug: Brentuximab Vedotin
18 Completed Are Newborns Conscious of the Placebo Effect? Result From an RCT in Osteopathy
Condition: Prematurity
Interventions: Other: Sham Osteopathic Manipulative Treatment;   Other: Standard care
19 Not yet recruiting Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
Condition: Venous Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
20 Not yet recruiting 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Conditions: High Risk MC4R Genotype;   Low Risk MC4R Genotype;   One Week or Less Antipsychotic Lifetime Exposure
Interventions: Drug: Ziprasidone;   Drug: aripiprazole, quetiapine, or risperidone

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years